Amino Innovations Develops Next-Generation Peptide Patch Platform to Redefine Everyday Wellness

Executive Summary

• Pangea Natural Foods’ subsidiary Amino Innovations introduced a next‑generation, bio‑dissolving peptide patch that delivers injectable‑equivalent doses without needles.
• The initial commercial rollout will feature two formulations: the “Wolverine Stack Patch” (BPC‑157 + Thymosin β4) for recovery and the TA‑1 patch for immune support.
• Management highlights the platform’s potential to unlock a large addressable market for peptide delivery in North America and globally, with further updates expected in Q4‑2025.

Key Details

• Technology: Bio‑dissolving lattice patch delivers peptides through skin layers; TSA‑friendly, shelf‑stable up to six months, manufactured in a cGMP‑certified facility with third‑party pharmaceutical‑grade testing.
• Formulations Launched:
• Wolverine Stack Patch – combines BPC‑157 and Thymosin β4 for muscle/tissue recovery and resilience.
• TA‑1 Patch – formulated to promote immune balance and strengthen natural defenses.
• Equivalence: Provides one‑to‑one dosing equivalence to traditional injectable forms, eliminating reconstitution, sterile handling, and measurement steps.
• Target Consumers: Active individuals, travelers, longevity enthusiasts seeking needle‑free peptide therapy for performance, recovery, and wellness.
• Commercial Timeline: Initial launch slated for Q4‑2025; additional updates on validation studies and market rollout to be provided later in the quarter.
• Leadership Comments:
• Justin Kirkland (CSO & Co‑Founder, Amino Innovations) emphasized the step forward in making peptide science accessible and mainstream.
• Pratap Sandhu (CEO, Pangea) noted the platform could “potentially unlock a breakthrough for the delivery of peptides” and expand total addressable market size.

Notable Quotes

• “These new formulations represent a significant step forward in our mission to make advanced peptide science accessible and effortless.” – Justin Kirkland, CSO & Co‑Founder, Amino Innovations
• “The development of this patch technology … could potentially unlock a breakthrough for the delivery of peptides and expand the total addressable market size … we look forward to providing additional updates during Q4‑2025.” – Pratap Sandhu, CEO, Pangea Natural Foods

Materiality Assessment: Material – Positive (introduces a novel revenue‑generating product line with significant market potential).